Ballentine Partners, LLC Danaher Corp Transaction History

Ballentine Partners, LLC

  • $5.81 Billion
  • Q3 2024

A detailed history of Ballentine Partners, LLC transactions in Danaher Corp stock. As of the latest transaction made, Ballentine Partners, LLC holds 17,769 shares of DHR stock, worth $4.31 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
17,769
Previous 17,963 1.08%
Holding current value
$4.31 Million
Previous $4.49 Million 10.05%
% of portfolio
0.09%
Previous 0.08%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024
SELL
$239.25 - $280.76 $46,414 - $54,467
-194 Reduced 1.08%
17,769 $4.94 Million
Q2 2024

Aug 06, 2024
BUY
$235.51 - $267.98 $267,774 - $304,693
1,137 Added 6.76%
17,963 $4.49 Million
Q1 2024

Apr 11, 2024
BUY
$224.58 - $256.19 $317,556 - $362,252
1,414 Added 9.17%
16,826 $4.2 Million
Q4 2023

Jan 23, 2024
SELL
$185.1 - $233.13 $924,204 - $1.16 Million
-4,993 Reduced 24.47%
15,412 $3.57 Million
Q3 2023

Oct 19, 2023
BUY
$233.08 - $265.59 $474,317 - $540,475
2,035 Added 11.08%
20,405 $5.06 Million
Q2 2023

Jul 26, 2023
BUY
$224.99 - $256.14 $1.12 Million - $1.27 Million
4,971 Added 37.1%
18,370 $4.41 Million
Q1 2023

Apr 27, 2023
BUY
$239.75 - $277.0 $156,077 - $180,327
651 Added 5.11%
13,399 $3.38 Million
Q4 2022

Jan 27, 2023
BUY
$241.42 - $282.29 $106,466 - $124,489
441 Added 3.58%
12,748 $0
Q3 2022

Oct 26, 2022
BUY
$247.06 - $1507.4 $356,507 - $2.18 Million
1,443 Added 13.28%
12,307 $3.18 Million
Q2 2022

Aug 09, 2022
BUY
$237.11 - $299.66 $29,875 - $37,757
126 Added 1.17%
10,864 $2.75 Million
Q1 2022

May 05, 2022
SELL
$257.27 - $315.76 $11,577 - $14,209
-45 Reduced 0.42%
10,738 $3.15 Million
Q4 2021

Feb 14, 2022
BUY
$292.08 - $329.01 $144,579 - $162,859
495 Added 4.81%
10,783 $3.55 Million
Q3 2021

Oct 27, 2021
SELL
$272.21 - $332.43 $38,926 - $47,537
-143 Reduced 1.37%
10,288 $3.13 Million
Q2 2021

Aug 12, 2021
SELL
$225.08 - $271.69 $64,147 - $77,431
-285 Reduced 2.66%
10,431 $2.8 Million
Q1 2021

May 11, 2021
BUY
$212.38 - $245.9 $14,654 - $16,967
69 Added 0.65%
10,716 $2.41 Million
Q4 2020

Jan 25, 2021
SELL
$212.5 - $245.46 $238,212 - $275,160
-1,121 Reduced 9.53%
10,647 $2.37 Million
Q3 2020

Oct 22, 2020
SELL
$177.16 - $215.33 $630,512 - $766,359
-3,559 Reduced 23.22%
11,768 $2.54 Million
Q2 2020

Jul 31, 2020
BUY
$128.7 - $176.83 $279,536 - $384,074
2,172 Added 16.51%
15,327 $2.71 Million
Q1 2020

Apr 23, 2020
BUY
$121.39 - $169.05 $597,481 - $832,064
4,922 Added 59.78%
13,155 $1.82 Million
Q4 2019

Jan 22, 2020
BUY
$133.47 - $153.48 $1,468 - $1,688
11 Added 0.13%
8,233 $1.26 Million
Q3 2019

Oct 21, 2019
BUY
$135.4 - $146.47 $23,153 - $25,046
171 Added 2.12%
8,222 $1.19 Million
Q2 2019

Jul 25, 2019
BUY
$124.88 - $143.73 $84,169 - $96,874
674 Added 9.14%
8,051 $1.15 Million
Q1 2019

May 09, 2019
BUY
$97.62 - $132.29 $6,052 - $8,201
62 Added 0.85%
7,377 $974,000
Q4 2018

Feb 04, 2019
BUY
$94.85 - $109.54 $49,132 - $56,741
518 Added 7.62%
7,315 $754,000
Q3 2018

Oct 30, 2018
BUY
$98.13 - $108.9 $4,710 - $5,227
48 Added 0.71%
6,797 $739,000
Q2 2018

Jul 19, 2018
BUY
$96.1 - $103.24 $136,077 - $146,187
1,416 Added 26.55%
6,749 $666,000
Q1 2018

Apr 26, 2018
SELL
$92.16 - $103.8 $21,012 - $23,666
-228 Reduced 4.1%
5,333 $522,000
Q4 2017

Feb 02, 2018
BUY
$85.26 - $94.62 $7,673 - $8,515
90 Added 1.65%
5,561 $516,000
Q3 2017

Nov 06, 2017
BUY
$79.29 - $88.45 $433,795 - $483,909
5,471
5,471 $469,000

Others Institutions Holding DHR

# of Institutions
2,430
Shares Held
563M
Call Options Held
3.94M
Put Options Held
4.11M
View Full List

About DANAHER CORP

DHR Quotes by TradingView
  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $177B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Ballentine Partners, LLC Portfolio

Follow Ballentine Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ballentine Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ballentine Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email